• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Serum Institute Of India

Adar Poonawalla
Scamsters cheat SII of Rs 1cr in Adar Poonawala's name, cops probe

In a shocker, some unknown scamsters have cheated the vaccine giant Serum Institute of India (SII) over at least Rs 1 crore by sending fraudulent messages in the name of its CEO Adar Poonawala.

  • Saturday, 10 September 2022
Govt Panel Recommends EUA For COVID-19 Vaccines Covovax, Corbevax, Anti-Covid Pill Molnupiravir
DCGI's EUA Nod To Covovax For 12-17 Yrs Age Group

The government has still not not taken a decision on vaccinating those aged below 15 years. The health ministry has consistently said that additional need for vaccination and inclusion of population for vaccination are examined constantly.

  • Wednesday, 09 March 2022
Cyrus Poonawalla
SII Chairman Cyrus Poonawalla Named Recipient Of Lokmanya Tilak National Award

The award ceremony will take place on August 13 and the award comprises cash prize of Rs one lakh and a memento.

  • Saturday, 31 July 2021
Aerum-Institute
Serum Institute To Manufacture 200mn Doses Of COVID19 Vaccine

New Delhi: A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100 million doses of safe and effective Covid-19 vaccines for India and low-and middle income countries. This brings the […]

  • Monday, 12 April 2021
Serum Institute Of India, Merck, IAVI Team Up To Develop Monoclonal Antibodies For Covid
Serum Institute Of India, Merck, IAVI Team Up To Develop Monoclonal Antibodies For Covid

New Delhi: IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research as innovative interventions to address the Covid-19 pandemic. The agreement builds on the advanced antibody discovery and optimization expertise of IAVI and Scripps Research, […]

  • Saturday, 10 April 2021
Serum Institute
COVID-19: Enrolment For Phase III Clinical Trials Of COVISHIELD Vaccine Completed

November: Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, and Indian Council of Medical Research (ICMR), the apex body in India for biomedical research, announce completion of enrolment of phase 3 clinical trials for COVISHIELD in India. ICMR and SII have further collaborated for clinical development COVOVAX (Novavax) developed by Novavax, […]

  • Friday, 09 April 2021
Serum Institute Aims To Have 100m Doses Of AstraZeneca Vaccine Ready By Dec
Serum Institute Aims To Have 100m Doses Of AstraZeneca Vaccine Ready By Dec

New Delhi: Serum Institute of India (SII) is ramping up production of AstraZeneca’s Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that same month, Bloomberg reported. If final-stage trial data show that AstraZeneca’s vaccine candidate is giving effective protection from the virus, SII […]

  • Friday, 09 April 2021
Oxford Covid-19 Vaccine ‘Encouraging' For Older Age Groups
Oxford Covid-19 Vaccine ‘Encouraging' For Older Age Groups

London: Covid-19 vaccine developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University produced a strong immune response in older adults. The results have raised hopes that it can protect the age groups most at risk from the virus. The study, published in The Lancet medical journal, suggest that those aged over 70, who are at […]

  • Friday, 09 April 2021
Aadar-Poonawalla
Every Indian Will Get Vaccinated For Covid-19 Probably By 2024: Adar Poonawalla

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla has said that every Indian will get vaccinated for Covid 19 probably by 2024. Speaking at a media event, Poonawalla said the Oxford AstraZeneca Covid-19 vaccine should be available for healthcare workers and elderly people by February 2021 and by April for the general public. […]

  • Friday, 09 April 2021
PM-Modi
PM Modi To Visit Serum Institute of India In Pune On November 28

Pune: Prime Minister Narendra Modi will visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine on Saturday, a senior official said on Thursday. The Central Drug Standard Control Organisation has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and […]

  • Friday, 09 April 2021
Adar Poonawalla
Serum Institute To Seek Emergency Use Authorisation For Covishield Vaccine In 2 Weeks: Poonawalla

New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation. […]

  • Friday, 09 April 2021
Adar Poonawalla
Adar Poonawalla Of Serum Institute Among 6 Named 'Asians Of The Year' By Singapore Daily

Singapore: Adar Poonawalla, the chief executive of the world’s largest vaccine manufacturer Serum Institute of India, is among the six people named “Asians of the Year” by  The Straits Times, a leading daily newspaper of Singapore, for their work in fighting the COVID-19 pandemic. Pune-based Serum Institute of India (SII) has collaborated with the University […]

  • Thursday, 08 April 2021
Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines
Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines

New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]

  • Wednesday, 07 April 2021
vaccines
Covaxin, Covishield New Fact-Sheets: Know Who Can’t Take Vaccines, the Side-effects

Bhubaneswar: With the ‘vaccine hesitancy’ getting manifested in nearly half a dozen districts– including the Capital City– in the State despite a mere 0.01 per cent showing any AEFI (adverse events following immunisation) signs, the two vaccine manufacturers – Bharat Biotech and Serum Institute India – have released fact-sheets that tell who are eligible for […]

  • Tuesday, 06 April 2021
Powerful Indians Making Aggressive Calls For Vaccines: Poonawalla
Vaccine Nationalism Threatens Target Of 2B Doses: Adar Poonawalla

New Delhi: Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries, including the US and India is likely to derail efforts to deliver 2 billion doses to poorer and middle-income nations. In an interview with a global news wire, Poonawalla said countries are holding tight to their supplies and […]

  • Saturday, 03 April 2021
scrollToTop

AdBlock Detected!

Our website is made possible by displaying ads to our visitors. Please supporting us by whitelisting our website.